709.8500 -4.05 (-0.57%)
NSE Jul 11, 2025 15:31 PM
Volume: 678.2K
 

Axis Direct
the company has a strong RoCE of ~32% and has zero net debt due to its strong operating cash flow generation. Therefore, we recommend BUY with a TP of Rs 1,740/share.
Prabhudas Lilladhar released a Buy report for Krishna Institute of Medical Sciences Ltd. with a price target of 725.0 on 30 Jun, 2025.
More from Krishna Institute of Medical Sciences Ltd.
Recommended